Positive and Negative Consequences of the Digital Transformation of the Pharmaceutical Industry

Author:

Karonsky Yeruslan Vladimirovich,Amirkhanov Aziz Abdullaevich

Abstract

The article is devoted to identifying the positive and negative consequences of the digital transformation of pharmaceutical companies in modern economic conditions. The purpose of the article is to identify the positive and negative consequences of the digital transformation of pharmaceutical companies in order to find ways to overcome the negative consequences. The authors analyzed the main trends in the development of the modern pharmaceutical industry in Russia, identified and systematized the positive and negative consequences of the influence of digitalization processes on it. The research methods include content analysis, statistical data analysis, description, generalization. According to the results of the study, it was revealed that one of the most important positive consequences of the digital transformation of pharmaceutical companies is to increase labor productivity, accelerate operations for the development of medicines and their promotion in the pharmaceutical market, as well as optimize and reduce the costs of pharmaceutical companies for the promotion of medicines in modern conditions. Among the negative consequences of the digital transformation of pharmaceutical companies in modern economic conditions, cybercrime and unemployment as a result of the automation of business processes of pharmaceutical companies, as well as the need to retrain employees as a result of the disappearance of some professions, were highlighted. In order to overcome the identified negative consequences of digital transformation on the pharmaceutical industry in Russia, it is necessary to address issues of strengthening cybersecurity, as well as the issue of retraining of employees and the redistribution of the labor market.

Publisher

Aurora Group, s.r.o

Subject

General Engineering

Reference16 articles.

1. Avdeenko S. Tsifra – eto novyi aktivnyi farmatsevticheskii ingredient // Daizhdest novostei tsifrovogo zdravookhraneniya. 2021. №10. URL: https://portal.egisz.rosminzdrav.ru/files.pdf (data obrashcheniya: 10.03.2023).

2. Bogatyuk S. Marketing s prepyatstviyami: kak prodvigat' lekarstva // RBK.pro. URL: https://pro.rbc.ru/demo/5e3c1a219a7947cba3a464cd (data obrashcheniya: 10.03.2023).

3. Golikova O. A. Tsifrovaya ekonomika Rossii: otkryvayushchiesya riski i vozmozhnosti / Golikova O. A., Ioda E. V. // Sotsial'no-ekonomicheskie yavleniya i protsessy. 2018. № 13 (4). S. 147-157.

4. Kashpurova O.V. Tsifrovaya ekonomika: riski i vozmozhnosti / Kashpurova O. V., Shcherbina A. S. // Molodaya nauka Sibiri: elektron. nauch. zhurn. 2020. № 4 (10). URL: http://mnv.irgups.ru/toma/410-2020 (data obrashcheniya: 10.03.2023).

5. Klunko N.S., Sirotkina N.V. Osnovnye trendy tsifrovoi transformatsii farmatsevticheskoi otrasli // Organizator proizvodstva. 2021. T.29. № 2. S. 90-97.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3